Skip to main content

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

Tratamientos endovasculares de neuroprotección y neuroreparación en la recuperación del ictus.

IP: Anna Rosell Novel
Collaborators: Anna Penalba Morenilla, Paula Garcia Rodriguez, Miguel García Gabilondo
Funding agency: Instituto de Salud Carlos III
Funding: 141570
Reference: PI22/01055
Duration: 01/01/2023 - 31/12/2025

RICORS-ICTUS

IP: Anna Rosell Novel
Collaborators: Marcel Lamana Vallverdu, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Maria Pilar Delgado Martínez, Jesús Pizarro Gonzálvez
Funding agency: Instituto de Salud Carlos III
Funding: 250214.8
Reference: RD21/0006/0007
Duration: 01/01/2022 - 31/12/2024

MULTI-BIO-TARGETS: una nueva estrategia para el manejo de ictus combinando biomarcadores pronósticos y neuroprotectores

IP: Olga Maisterra Santos
Collaborators: Joan Montaner Villalonga, Anna Penalba Morenilla, Paula Garcia Rodriguez
Funding agency: Instituto de Salud Carlos III
Funding: 363907.5
Reference: PI18/00804
Duration: 01/01/2019 - 30/06/2023

Discovery and clinical usefulness of blood biomarkers in stroke-associated pneumonia. The PROteomics and Transcriptomics in lEUkocyte Subpopulations (PROTEUS) study

IP: Olga Maisterra Santos
Collaborators: Joan Montaner Villalonga, Anna Penalba Morenilla
Funding agency: Fundació La Marató de TV3
Funding: 191375
Reference: 20170630
Duration: 01/01/2018 - 31/12/2021

Related news

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more
Luca Basile

Luca Basile

Administration and Management
Microbiology
Read more
Ana  Leon  Espitia

Ana Leon Espitia

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.